BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 28.50
0.00 (0.00%)
Oct 6, 2026, 10:59 AM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 729.94 million as of October 9, 2026. It is the 36,159th most valuable company in the world and the 2,169th biggest in Taiwan. Its market cap has decreased by 14.16% in one year.
Market Cap
729.94M
Enterprise Value
675.68M
Revenue
258.04M
Global Rank
Country Rank
#2,169 Taiwan
PE Ratio
17.92
ChartMarket Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 729.94M, a decrease of -53.83%. That is a compound annual growth rate of -8.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 729.94M | -8.06% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Level Biotechnology | 1.02B |
| TCI GENE | 971.03M |
| MegaPro Biomedical | 896.38M |
| NatureWise Biotech & Medicals | 833.45M |
| Lukas Biomedical | 774.68M |
| Neith | 703.95M |
| Taiwan Advance Bio-Pharmaceutical | 679.50M |
| Meribank Biotech | 649.74M |